Novartis reported CHF1.69B in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Alcon AG ALC:SW 141.33M 26.67M
Amgen AMGN:US $ 1317M 159M
Artemis Alpha ATS:LN -2676900000 1.65B
AstraZeneca AZN:LN 29568.96M 177.38M
Bayer BAYN:GR € -298M 3589M
Biogen BIIB:US $ 1058M 754.2M
Bristol Myers Squibb BMY:US $ 1421M 143M
Eli Lilly And LLY:US $ 952.5M 950.4M
Fresenius FRE:GR € 383M 30M
Fresenius Medical Care FME:GR € 147M 10.36M
Galapagos GLPG:NA € -19.03M 5.72M
Genmab GEN:DC DK 1891M 1426M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 83800M 96400M
Hikma Pharmaceutical HIK:LN 14.21B 1.42B
Johnson & Johnson JNJ:US $ 4814M 335M
Lonza Group LONN:SW 492M 2.13B
Merck MRK:GR € 867M 14M
Merk MRK:US $ 3944M 366M
Novartis NOVN:VX SF 1694M 528M
Novartis NVS:US $ 1694M 528M
Orion ORNBV:FH € 66.1M 8.8M
Pfizer PFE:US $ 9905M 2042M
Philips PHIA:NA € -22M 130M
Recordati REC:IM € 54.68M 42.04M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M